Pune: The Serum Institute of India (SII) has filed a Rs 100-crore defamation suit against a Chennai-based volunteer who took part in the COVID-19 vaccine ‘Covishield’ trial and later claimed to suffer from neurological and psychological issues as a result of taking the dose.
The 40-year-old participant has sought Rs 5 crore as compensation from SII, citing side effects of virtual neurological breakdown and impairment of cognitive functions after taking the dose of the vaccine.
‘Covishield’, a vaccine for COVID-19, is being developed by the University of Oxford and AstraZeneca in collaboration with the Pune-based SII.
Refuting the trial volunteer’s claims, SII said it would seek damages of Rs 100 crore damages for “malicious and misconceived allegations”.
“The allegations in the notice are malicious and misconceived. While the Serum Institute of India is sympathetic to the volunteer’s medical condition, there is absolutely no correlation with the vaccine trial and the medical condition of the volunteer. The volunteer is falsely laying the blame for his medical problems on the Covid vaccine trial,” it said in a statement.
A criminal case has also been filed against the volunteer and he is likely to receive the notice by Monday.